Description: Veritas Pharma Inc., through its subsidiary, Cannevert Therapeutics Ltd. operates as a pharmaceutical and IP development company. It develops proprietary cannabis strains for chronic and acute pains, nausea and vomiting, and post-traumatic stress disorders. The company was formerly known as Seashore Organic Medicine Inc. and changed its name to Veritas Pharma Inc. in December 2015. Veritas Pharma Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.
Home Page: www.veritaspharmainc.com
2220 Horizon Drive East
Kelowna,
BC
V1Z 3L4
Canada
Phone:
416-918-6785
Officers
| Name | Title |
|---|---|
| Mr. Lorne Mark Roseborough | Chairman & CEO |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.4322 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | April |
| Full Time Employees: | 0 |